Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERENUMAB vs ERTAPENEM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERENUMAB vs ERTAPENEM: Safety Overview

Metric ERENUMAB ERTAPENEM
Total FAERS Reports 1,183 4,069
Deaths Reported 363 223
Death Rate 30.7% 5.5%
Hospitalizations 498 1,617
Average Patient Age 45.6 yrs 64.1 yrs
% Female Patients 93.4% 54.5%
FDA Approval Date N/A Apr 16, 2018
Manufacturer Amgen Inc Merck Sharp & Dohme LLC
Route SUBCUTANEOUS INTRAMUSCULAR
Marketing Status N/A Prescription